Dian Silvia, Simeone Monica, Rossi Barbara, Scaparrotta Giuseppe, Fragasso Antonio, Carretta Giovanni, Capizzi Alfio, Donato Daniele, Cianci Vito, Cattelan Anna Maria, Calò Lorenzo A
Clin Nephrol. 2021 Mar;95(3):151-156. doi: 10.5414/CN110330.
The recent SARS-CoV-2 outbreak represents a global health emergency, and dialysis patients are a high-risk population. Patients with end-stage renal disease (ESRD) in hemodialysis facilities require specific protocols to be planned and promptly executed for the management of suspected/confirmed cases of COVID-19 with respect to prevention, protection, screening, and isolation.
In order to prevent the spread of SARS-CoV-2 in our Hemodialysis Unit, we adopted individual protection measures accompanied by measures to minimize contacts among hemodialysis patients with suspicious symptoms as well as other patients and medical staff. We provided our patients detailed instructions to be followed in the event of their having symptoms compatible with SARS-CoV-2 infection or having contacts with SARS-CoV-2-positive subjects. Ultimately, four possible scenarios and care paths were developed and implemented in collaboration with the Infectious Diseases and Emergency Units at the Padua University Hospital.
The application of this strategy has resulted in the nearly 200 patients treated in our hemodialysis facilities while there were only 2 cases of COVID-19 (1% incidence rate) with no deaths.
We attribute the low COVID-19 incidence noted so far for patients in our hemodialysis facilities to the early detection and prompt isolation of suspected patients per our specific plan along with the prompt application of preventive measures.
近期新型冠状病毒肺炎(SARS-CoV-2)疫情构成全球卫生紧急事件,透析患者属于高危人群。血液透析机构中的终末期肾病(ESRD)患者需要制定并迅速执行特定方案,以便在预防、防护、筛查及隔离方面管理新型冠状病毒肺炎疑似/确诊病例。
为防止SARS-CoV-2在我们的血液透析科传播,我们采取了个人防护措施,并采取措施尽量减少有可疑症状的血液透析患者与其他患者及医护人员之间的接触。我们向患者提供了详细的指导说明,告知他们在出现与SARS-CoV-2感染相符的症状或与SARS-CoV-2阳性者接触时应遵循的事项。最终,我们与帕多瓦大学医院的传染病科和急诊科合作,制定并实施了四种可能的情况及护理路径。
应用该策略后,我们血液透析机构治疗了近200名患者,而新型冠状病毒肺炎病例仅2例(发病率1%),无死亡病例。
我们将目前血液透析机构中患者的新型冠状病毒肺炎低发病率归因于按照我们的特定计划对疑似患者进行早期检测和迅速隔离,以及及时采取预防措施。